European Journal of Radiology
Volume 64, Issue 3 , Pages 426-431 , December 2007

Factors associated with one step surgery in case of non-palpable breast cancer

Received 15 December 2006 ,Revised 19 February 2007 ,Accepted 23 February 2007.

References 

  1. Liberman L. Percutaneous image-guided core breast biospy: state of the art at the millennium. AJR. 2000;174:1191–1199
  2. Edge SB, Ottesen RA, Lepisto EM, et al. Surgical biopsy to diagnose breast cancer adversely affects outcomes of breast cancer care: finding from the National Comprehensive Cancer Network. In: Proceedings of the 28th Annual San Antonio Breast Cancer Symposium, Abstr. 1.32. San Antonio, USA, December 08–11. 2005;
  3. Liberman L, La Trenta LR, Dershaw DD, et al. Impact of core biopsy on the surgical management of impalpable breast cancer. AJR. 1997;168:495–499
  4. Smith DN, Christian RL, Meyer JE. Large-core needle biopsy of nonpalpable breast cancers: the impact on subsequent surgical excisions. Arch Surg. 1997;132:256–259
  5. Lind DS, Minter R, Steinbach B, et al. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer. J Surg Res. 1998;78:23–26
  6. Kaufman CS, Delbecq R, Jacobson L. Excising the reexcision: stereotactic core-needle biopsy decreases need for reexcision of breast cancer. World J Surg. 1998;22:1023–1028
  7. Morrow M, Venta L, Stinson T, Bennet C. Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg. 2001;233:537–541
  8. Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology. 2001;218:497–502
  9. Jackman RJ, Marzoni FA, Finkelstein SI, Shepard MJ. Benefits of diagnosing nonpalpable breast cancer with stereotactic large-core needle biopsy: lower costs and fewer operations. Radiology. 1996;201:p311;[Abstract]
  10. Liberman L, Goodstine SL, Dershaw DD, et al. One operation after percutaneous diagnosis of nonpalpable breast cancer: frequency and associated factors. AJR. 2002;178:673–679
  11. Flanagan FL, McDermott MD, Barton PT, et al. Invasive breast cancer: mammographic measurement. Radiology. 1996;199:819–823
  12. Gallegos Hernandez JF, Tanis PJ, Deurloo EE, et al. Radio-guided surgery improves outcome of therapeutic excision in non-palpable invasive breast cancer. Nucl Med Commun. 2004;25:227–232
  13. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455–1461
  14. Tartter PI, Bleiweiss IJ, Levchenko S. Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation. J Am Coll Surg. 1997;185:268–273
  15. Verkooijen HM, Borel Rinkes IHM, Peeters PHM, et al. Impact of stereotactic large-core needle biopsy on diagnosis and surgical treatment of non-palpable breast cancer. Eur J Surg Oncol. 2001;27:244–249
  16. Liberman L, Cohen MA, Dershaw DD, et al. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR. 1995;164:1111–1113
  17. Gisvold JJ, Goellner JR, Grant CS, et al. Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques. AJR. 1994;162:815–820
  18. Pijnapple RM, van Dalen A, Borel Rinkes IHM, van den Tweel JG, Mali WPT. The diagnostic accuracy of core biopsy in palpable and non-palpable breast lesions. EJR. 1997;24:120–123
  19. Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni FA, Finkelstein SI, Shepard MJ. Stereotactic, automated, large-core biospy of breast lesions: false-negative and histologic underetsimation rates after long-term follow-up. Radiology. 1999;210:799–805
  20. Liberman L, Dershaw DD, Rosen PP, et al. Sterotaxic core biospy of breast carcinoma: accuracy at predicting invasion. Radiology. 1995;194:379–381
  21. Verkooijen HM, Peeters PHM, Buskens E, et al. Diagnostic accuracy of large-core-needle biopsy for nonpalpable breast disease: a meta-analysis. Br J Cancer. 2000;82:1017–1021
  22. Carmon M, Rivkin L, Abu-Dalo R, et al. Increased mammographic screening and use of percutaneous image-guided core biopsy in non-palpable breast cancer: impact on surgical treatment. Isr Med Assoc J. 2004;6:326–328
  23. Won B, Reynolds HE, Lazaridis CL, Jackson V. Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underetsimation of disease. AJR. 1999;173:227–229
  24. Darling MLR, Smith DN, Lester SC, et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large core needle breast biopsy: results of surgical excision. AJR. 2000;175:1341–1346
  25. Liberman L, Dershaw DD, Rosen PP, Morris EA, Cohen MA, Abramson AF. Core needle biopsy of synchronous ipsilateral breast lesions: impact on treatment. AJR. 1996;166:1429–1432
  26. Berg WA, Gilbreath PL. Multicentric and multifocal cancer: whole breast US in preoperative evaluation. Radiology. 2000;214:59–66
  27. Liberman L, Kaplan J, Van Zee KJ, et al. Bracketing wires for preoperative breast needle localization. AJR. 2001;177:565–572
  28. Liberman L. Pathologic analysis of sentinel lymph nodes in breast cancer. Cancer. 2000;88:971–977[Editorial]

PII: S0720-048X(07)00110-6

doi: 10.1016/j.ejrad.2007.02.033

European Journal of Radiology
Volume 64, Issue 3 , Pages 426-431 , December 2007